Chemists develop clickable tryptophan modification strategy for late-stage diversification of native peptides

Peptides are gradually emerging as middle-sized therapeutic agents for addressing unmet medical needs. Compared to small-molecule drugs, peptides can target complex biological processes more precisely while being generally less complex and more cost-effective than large biological drugs such as antibodies.